When:
Thursday, May 4, 2017
10:00 AM - 11:00 AM CT
Where: Robert H Lurie Medical Research Center, Gray Seminar Room, 303 E. Superior, Chicago, IL 60611 map it
Audience: Faculty/Staff - Student - Post Docs/Docs - Graduate Students
Contact:
Carson Nestler
(312) 503-5229
Group: Biochemistry & Molecular Genetics Seminar Series
Category: Lectures & Meetings
The Department of Biochemistry and Molecular Genetics Departmental Seminar Series presents:
Benjamin D. Singer, MD
Assistant Professor of Medicine (Pulmonary and Critical Care)
Northwestern University Feinberg School of Medicine
Regulatory T (Treg) cells, which express the master transcription factor Foxp3, play an essential role in limiting over-exuberant immune system activation and maintaining immune homeostasis. Treg cells also possess recently understood functions that directly repair tissue damage. In contrast to other T cell subsets, Treg cells carry a lineage-specifying CpG hypomethylation pattern that becomes disrupted in inflammatory environments such as the alveolar space following acute lung injury and the acute respiratory distress syndrome (ARDS). A small molecule inhibitor of DNA methyltransferase—5-aza-2’-deoxycitidine—can mitigate methylation within Treg cells and enhance their suppressive phenotype and pro-resolution function. The isoform of DNA methyltransferase responsible for maintenance DNA methylation, Dnmt1, uses the adapter protein Uhrf1 to target its catalytic activity to hemi-methylated DNA. New data suggest that ablation of Uhrf1 in the Foxp3+ lineage disrupts Treg cell epigenetic stability and leads to widespread immunopathology. Exploration of the T cell chromatin landscape and transcriptional profile during development, maintenance, and response to inflammation could reveal druggable targets for conditions associated with severe inflammation and tissue damage, including ARDS.